Pharmacokinetics of furegrelate after oral administration to normal humans

Furegrelate sodium is a thromboxane synthetase inhibitor with potential for the treatment of various diseases including hypertension, thrombosis, and renal disorders. The absorption and disposition of the parent drug in normal male volunteers have been studied after single- and multiple-dose oral ad...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical research 1989, Vol.6 (1), p.53-57
Main Authors: LAKINGS, D. B, FRIIS, J. M, LUNAN, C. M, VANDERLUGT, J. T, SCOTT MOHRLAND, J
Format: Article
Language:English
Subjects:
Administration, Oral
Antihypertensive agents
Benzofurans - pharmacokinetics
Biological and medical sciences
Cardiovascular system
Dose-Response Relationship, Drug
Humans
Male
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Furegrelate sodium is a thromboxane synthetase inhibitor with potential for the treatment of various diseases including hypertension, thrombosis, and renal disorders. The absorption and disposition of the parent drug in normal male volunteers have been studied after single- and multiple-dose oral administration. The results from the single-dose study indicate that furegrelate is rapidly absorbed, with a Tmax of 1.0-1.7 hr, has an apparent terminal disposition rate constant of 0.12-0.17 hr-1, and is eliminated primarily by the kidney, with 62-78% of the dose excreted as parent drug. After multiple-dose oral administration for 4.5 days using a b.i.d. dosing regimen, no apparent change in the absorption, disposition, and elimination kinetics is detected and only a slight potential for drug accumulation is observed.
ISSN:0724-8741
1573-904X
DOI:10.1023/A:1015899602741